LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 22 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,225,600 | -3.7% | 760,000 | +27.1% | 0.58% | +7.7% |
| Q2 2023 | $4,389,320 | +88.1% | 598,000 | +2.7% | 0.54% | +15.5% |
| Q1 2023 | $2,333,820 | +194.6% | 582,000 | +139.5% | 0.47% | +183.1% |
| Q4 2022 | $792,180 | +93.7% | 243,000 | +120.9% | 0.17% | +110.1% |
| Q3 2022 | $409,000 | +131.1% | 110,000 | +91.9% | 0.08% | +119.4% |
| Q2 2022 | $177,000 | -30.3% | 57,335 | +20.5% | 0.04% | -45.5% |
| Q1 2022 | $254,000 | +74.0% | 47,600 | +58.7% | 0.07% | +65.0% |
| Q4 2021 | $146,000 | -45.1% | 30,000 | 0.0% | 0.04% | -47.4% |
| Q3 2021 | $266,000 | -2.9% | 30,000 | 0.0% | 0.08% | +1.3% |
| Q2 2021 | $274,000 | -44.2% | 30,000 | 0.0% | 0.08% | -46.4% |
| Q1 2021 | $491,000 | – | 30,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,353,141 | $13,083,464 | 0.76% |
| Integral Health Asset Management, LLC | 760,000 | $4,225,600 | 0.58% |
| Prosight Management, LP | 321,154 | $1,785,616 | 0.57% |
| Parkman Healthcare Partners LLC | 355,957 | $1,979,121 | 0.36% |
| Ikarian Capital, LLC | 514,101 | $2,858,401 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $8,676,380 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $5,560,000 | 0.04% |
| UBS OCONNOR LLC | 262,265 | $1,458,193 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,614 | $626,134 | 0.02% |
| Point72 Asset Management, L.P. | 825,000 | $4,587,000 | 0.01% |